STOCK TITAN

Insider sale reported for RARE (NASDAQ: RARE) — 8,135 shares for $185,486

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RARE reported an insider sale filing under Form 144. The filing lists proposed sales of Performance Shares: 688 and Restricted Stock: 5,330, both dated 03/01/2024. It also records a sale by KARAH PARSCHAUER of 8,135 common shares on 03/02/2026 for $185,485.61.

Positive

  • None.

Negative

  • None.

Insights

Forms show an insider sale and proposed issuer-held share sales.

The filing lists proposed registrations or planned sales of 688 performance shares and 5,330 restricted shares dated 03/01/2024. It separately reports an actual disposition of 8,135 common shares on 03/02/2026 for $185,485.61.

Cash‑flow treatment for the proposed shares and any resale mechanics are not detailed in the excerpt; subsequent filings or transaction confirmations would state settlement method and who receives proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RARE's Form 144 show about insider sales?

The Form 144 reports an insider sale and planned sales. It records 8,135 common shares sold on 03/02/2026 for $185,485.61, and proposed sales of 688 performance and 5,330 restricted shares dated 03/01/2024.

Who sold shares according to the RARE Form 144?

Karah Parschauer is named as the seller for the reported transaction of 8,135 common shares on 03/02/2026, with an aggregate amount of $185,485.61 shown in the excerpt.

How many performance and restricted shares are listed for potential sale in RARE's filing?

The filing lists 688 performance shares and 5,330 restricted stock, both dated 03/01/2024. The excerpt labels these securities under "Securities To Be Sold."

Does the Form 144 excerpt state who receives proceeds from the sales?

The excerpt does not specify proceeds recipients for the proposed sales. The recorded sale shows an aggregate $185,485.61 amount for 8,135 shares, but payee details are not provided in the excerpt.

Are the listed proposed sales already completed in the RARE filing?

The excerpt separates "Securities To Be Sold" (proposed items dated 03/01/2024) from reported sales. Only the 8,135-share disposition on 03/02/2026 is shown as sold; proposed items appear as planned, not confirmed settled.
Ultragenyx Pharm

NASDAQ:RARE

View RARE Stock Overview

RARE Rankings

RARE Latest News

RARE Latest SEC Filings

RARE Stock Data

2.05B
93.24M
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO